As of Mar 28
| -1.50 / -1.01%|
The 15 analysts offering 12-month price forecasts for Moderna Inc have a median target of 208.00, with a high estimate of 506.00 and a low estimate of 93.00. The median estimate represents a +41.64% increase from the last price of 146.85.
The current consensus among 21 polled investment analysts is to Buy stock in Moderna Inc. This rating has held steady since March, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.